ATE87921T1 - Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen. - Google Patents

Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen.

Info

Publication number
ATE87921T1
ATE87921T1 AT88305408T AT88305408T ATE87921T1 AT E87921 T1 ATE87921 T1 AT E87921T1 AT 88305408 T AT88305408 T AT 88305408T AT 88305408 T AT88305408 T AT 88305408T AT E87921 T1 ATE87921 T1 AT E87921T1
Authority
AT
Austria
Prior art keywords
alkyl
substituted
cycloalkylamides
8beta
ergolines
Prior art date
Application number
AT88305408T
Other languages
English (en)
Inventor
Mark M Foreman
William L Garbrecht
Gifford P Marzoni
Kathleen R Whitten
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE87921T1 publication Critical patent/ATE87921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88305408T 1987-06-15 1988-06-14 Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen. ATE87921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6228587A 1987-06-15 1987-06-15
EP88305408A EP0296748B1 (de) 1987-06-15 1988-06-14 Cycloalkylamide von (8beta)-1-Alkyl-6-(substituierten) Ergolinen

Publications (1)

Publication Number Publication Date
ATE87921T1 true ATE87921T1 (de) 1993-04-15

Family

ID=22041482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88305408T ATE87921T1 (de) 1987-06-15 1988-06-14 Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen.

Country Status (22)

Country Link
EP (1) EP0296748B1 (de)
JP (1) JP2653835B2 (de)
KR (1) KR960010454B1 (de)
CN (1) CN1019451B (de)
AT (1) ATE87921T1 (de)
AU (1) AU613641B2 (de)
CA (1) CA1339661C (de)
DE (1) DE3880022T2 (de)
DK (1) DK322588A (de)
EG (1) EG18586A (de)
ES (1) ES2054806T3 (de)
HK (1) HK77693A (de)
HU (2) HU203344B (de)
IE (1) IE61884B1 (de)
IL (1) IL86725A (de)
MX (1) MX11866A (de)
NZ (1) NZ225022A (de)
PH (1) PH24309A (de)
PT (1) PT87716B (de)
SU (1) SU1597103A3 (de)
UA (1) UA6022A1 (de)
ZA (1) ZA884222B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902691A (en) * 1988-12-19 1990-02-20 Eli Lilly And Company Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
IT1232692B (it) * 1989-08-04 1992-03-04 Poli Ind Chimica Spa Derivati ergolinici con attivita' dopaminergica
US5043341A (en) * 1990-04-11 1991-08-27 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
US5141944A (en) * 1990-04-11 1992-08-25 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
JPH11503757A (ja) * 1995-04-18 1999-03-30 イーライ・リリー・アンド・カンパニー ５−ｈｔ▲下７▼レセプターにおいて生理学的および病理学的機能を生じるエルゴリン化合物の使用方法
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
US6175692B1 (en) 1998-05-26 2001-01-16 Canon Kabushiki Kaisha Focus detecting device, distance measuring device, and optical apparatus for adjusting focus
WO2011079313A1 (en) 2009-12-23 2011-06-30 Map Pharmaceuticals, Inc. Novel ergoline analogs
CN102775402B (zh) * 2011-05-13 2015-08-26 上海现代制药股份有限公司 一种制备二氢麦角酸的中间体及其制备方法
CN103827113A (zh) 2011-06-23 2014-05-28 Map药物公司 新型氟麦角碱类似物
CA2859173A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
AU2012355983A1 (en) 2011-12-21 2015-01-22 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386441A (de) * 1961-02-17 1965-01-15 Sandoz Ag Verfahren zur Herstellung von am Indolstickstoff substituierten Derivaten der Lysergsäure-Reihe
GB982737A (en) * 1961-05-08 1965-02-10 Westminster Bank Ltd Improvements in or relating to lysergic acid compounds
GB996062A (en) * 1961-07-13 1965-06-23 Westminster Bank Ltd Improvements in or relating to lysergic acid compounds

Also Published As

Publication number Publication date
SU1597103A3 (ru) 1990-09-30
JPS6416781A (en) 1989-01-20
IL86725A0 (en) 1988-11-30
EP0296748A1 (de) 1988-12-28
CN1030586A (zh) 1989-01-25
AU1765288A (en) 1988-12-15
PT87716A (pt) 1988-07-01
HU203344B (en) 1991-07-29
ES2054806T3 (es) 1994-08-16
DK322588D0 (da) 1988-06-14
ZA884222B (en) 1990-02-28
CN1019451B (zh) 1992-12-16
UA6022A1 (uk) 1994-12-29
CA1339661C (en) 1998-02-10
DE3880022T2 (de) 1993-08-19
EG18586A (en) 1993-08-30
KR890000482A (ko) 1989-03-14
KR960010454B1 (ko) 1996-08-01
IE61884B1 (en) 1994-11-30
AU613641B2 (en) 1991-08-08
IL86725A (en) 1993-01-14
HU211235A9 (en) 1995-11-28
HUT47271A (en) 1989-02-28
NZ225022A (en) 1990-07-26
JP2653835B2 (ja) 1997-09-17
IE881788L (en) 1988-12-15
PT87716B (pt) 1992-10-30
PH24309A (en) 1990-05-29
DE3880022D1 (de) 1993-05-13
MX11866A (es) 1993-12-01
HK77693A (en) 1993-08-13
EP0296748B1 (de) 1993-04-07
DK322588A (da) 1989-02-01

Similar Documents

Publication Publication Date Title
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
ES538418A0 (es) Un derivado de indol-3-carboxamida
DE3880022T2 (de) Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen.
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ZA901277B (en) Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
HK1004750A1 (en) Bicyclic sulfonamide derivatives and their preparation their use and formulations containing them
GB8706662D0 (en) Anti-arrhythmia agents
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
GR3005444T3 (de)
DK0420224T3 (da) Anthihepatopatisk middel
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI872997A (fi) Amidderivat.
ATE189813T1 (de) Prostaglandin-i-analoga

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee